U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

Author: Ho Samuel   Aqel Bashar   Dieperink Eric   Liu Shanglei   Tetrick Lori   Falck-Ytter Yngve   DeComarmond Charles   Smith Coleman   McKee Daniel   Boyd William   Kulig Clark   Bini Edmund   Pedrosa Marcos  

Publisher: Springer Publishing Company

ISSN: 0163-2116

Source: Digestive Diseases and Sciences, Vol.56, Iss.3, 2011-03, pp. : 880-888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content